Polyglutamine neurodegenerative diseases and regulation of transcription: Assembling the puzzle

Genes and Development

Volumn 20, Issue 16, 2006, Pages 2183-2192

  Riley, Brigit E ^a,c   Orr, Harry T ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Gene expression; Neurodegenerative disease; Polyglutamine; Transcription; Trinucleotide repeats

Indexed keywords

ATAXIN 1; ATAXIN 3; ATAXIN 7; CELL NUCLEUS RECEPTOR; MUTANT PROTEIN; POLYGLUTAMINE; PROTEIN ATAXIN 17; TATA BINDING PROTEIN; UNCLASSIFIED DRUG;

CHROMATIN STRUCTURE; DEGENERATIVE DISEASE; DENTATORUBROPALLIDOLUYSIAN ATROPHY; GENE EXPRESSION; GENETIC TRANSCRIPTION; MACHADO JOSEPH DISEASE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; NEURODEGENERATIVE DISEASES; PEPTIDES; PROTEIN BINDING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 33747359908     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1436506     Document Type: Review

References (83)

1. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R., and Finkbeiner, S. 2004. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431: 805-810.
2. Borden, K. 2002. Pondering the promyelocytic leukemia protein (PML) puzzle: Possible functions for PML nuclear bodies. Mol. Cell. Biol. 22: 5259-5269.
3. Browne, S.E. and Beal, M.F. 2004. The energetics of Huntington's disease. Neurochem. Res. 29: 531-546.
4. Burnett, B., Li, F., Randall, N., and Pittman, R.N. 2003. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum. Mol. Genet. 12: 3195-3205.
5. Chai, Y., Berke, S.S., Cohen, R.E., and Paulson, H.L. 2004. Polyubiquitin binding by the polyglutamine disease protein Ataxin-3 links its normal function to protein surveillance pathways. J. Biol. Chem. 279: 3605-3611.
6. David, G., Abbas, N., Stevanin, G., Durr, A., Yvert, G., Cancel, G., Weber, C., Imbert, G., Saudou, F., Antoniou, E., et al. 1997. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat. Genet. 17: 65-70.
7. Donaldson, K.M., Wei Li, W., Ching, K.A., Batalov, S., Chih-Cheng Tsai, C.-C., and Joazeiro, C.A.P. 2003. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc. Natl. Acad. Sci. 100: 8892-8897.
8. Dunah, A.W., Jeong, H., Griffin, A., Kim, Y.-M., Standaert, D.G., Hersch, S.M., Mouradian, M.M., Young, A.B., Tanese, N., and Dimitri Krainc, D. 2002. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296: 2238-2243.
9. Emamian, E.S., Kaytor, M.D., Duvick, L.A., Zu, T., Susan, K., Tousey, S.K., Zoghbi, H.Y., Clark, H.B., and Orr, H.T. 2003. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 38: 375-387.
10. Enevoldson, T.P., Sanders, M.D., and Harding, A.E. 1994. Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families. Brain 117: 445-460.
11. Fernandez-Funez, P., Nino-Rosales, M.L., de Gouyon, B., She, W.C., Luchak, J.M., Martinez, P., Turiegano, E., Benito, J., Capovilla, M., Skinner, P.J., et al. 2000. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408: 101-106.
12. Ferrante, R.J., Kubilus, J.K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N.W., Ratan, R.R., Luthi-Carter, R., et al. 2003. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 23: 9418-9427.
13. Freeman, B.C. and Yamamoto, K.R. 2001. Continuous recycling: A mechanism for modulatory signal transduction. Trends Biochem. Sci. 26: 285-290.
14. Gardian, G., Browne, S.E., Choi, D.K., Klivenyi, P., Gregorio, J., Kubilus, J.K., Ryu, H., Langley, B., Ratan, R.R., Ferrante, R.J., et al. 2005. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J. Biol. Chem. 280: 556-563.
15. Gatchel, J.R. and Zoghbi, H.Y. 2005. Diseases of unstable repeat expansion: Mechanism and common principles. Nat. Rev. Genet. 6: 743-755.
16. Gill, G. and Tjian, R. 1992. Eukaryotic coactivators associated with the TATA box binding protein. Curr. Opin. Genet. Dev. 2: 236-242.
17. Gunawardena, S. and Goldstein, L.S. 2005. Polyglutamine diseases and transport problems: Deadly traffic jams on neuronal highways. Arch. Neurol. 62: 46-51.
18. Helmlinger, D., Hardy, S., Sasorith, S., Klein, F., Robert, F., Weber, C., Miguet, L., Potier, N., Van-Dorsselaer, A., Wurtz, J.M., et al. 2004. Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. Hum. Mol. Genet. 13: 1257-1265.
19. Helmlinger, D., Hardy, S., Abou-Sleymane, G., Eberlin, A., Bowman, A.B., Gansmüller, A., Picaud, S., Zoghbi, H.Y., Trottier, Y., Tora, L., et al. 2006. Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction. PLoS Biol. 4: 432-445.
20. Hockly, E., Richon, V.M., Woodman, B., Smith, D.L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P.A., et al. 2003. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. 100: 2041-2046.
21. Hughes, R.E. 2002. Polyglutamine disease: Acetyltransferases awry. Curr. Biol. 12: R141-R143.
22. Irwin, S., Vandelft, M., Howell, J.L., Graczyk, J., Orr, H.T., and Truant, R. 2005. RNA association and nucleocytoplasmic shuttling by ataxin-1. J. Cell Sci. 118: 233-24 2.
23. Johnson, E. 2004. Protein modification by SUMO. Annu. Rev. Biochem. 73: 355-382.
24. Katsuno, M., Adachi, H., Kume, A., Li, M., Nakagomi, Y., Niwa, H., Sang, C., Kobayashi, Y., Doyu, M., and Sobue, G. 2002. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35: 843-854.
25. Katsuno, M., Adachi, H., Doyu, M., Minamiyama, M., Sang, C., Kobayashi, Y., Inukai, A., and Sobue, G. 2003. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 9: 768-773.
26. Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D., and Housman, D. 1999. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc. Natl. Acad. Sci. 96: 11404-11409.
27. Klement, I.A., Skinner, P.J., Kaytor, M.D., Yi, H., Hersch, S.M., Clark, H.B., Zoghbi, H.Y., and Orr, H.T. 1998. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95: 41-53.
28. Koide, R., Kobayashi, S., Shimohata, T., Ikeuchi, T., Maruyama, M., Saito, M., Yamada, M., Takahashi, H., and Tsuji, S. 1999. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATAbinding protein gene: A new polyglutamine disease. Hum. Mol. Genet. 18: 2047-2053.
29. Komuro, A., Saeki, M., and Kato, S. 1999a. Npw38, a novel protein possessing a WW domain capable of activating basal transcription. Nucleic Acids Res. 27: 1957-1965.
30. _. 1999b. Association of two nuclear proteins, Npw38 and NpwBP, via the interaction between WW domain and a novel proline-rich motif containing glycine and arginine. J. Biol. Chem. 274: 36513-36519.
31. Kordasiewicz, H.B., Thompson, R.M., Clark, H.B., and Gomez, C.M. 2006. C-termini of P/Q-type Ca2+ channel αta subunits translocate to nuclei and promote polyglutamine-mediated toxicity. Hum. Mol. Genet. 15: 1587-1599.
32. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E., and Fischbeck, K.H. 1991. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352: 77-79.
33. La Spada, A.R., Fu, Y.H., Sopher, B.L., Libby, R.T., Wang, X., Li, L.Y., Einum, D.D., Huang, J., Possin, D.E., Smith, A.C., et al. 2001. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron 31: 913-927.
34. Li, S.-H., Cheng, A.L., Zhou, H., Lam, S., Rao, M., Li, H., and Li, X.-J. 2002a. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell. Biol. 22: 1277-1287.
35. Li, F., Macfarlan, T., Pittman, R.N., and Chakravarti, D. 2002b. Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J. Biol. Chem. 277: 45004-45012.
36. Lin, X., Antalffy, B., Kang, D., Orr, H.T., and Zoghbi, H.Y. 2000. Polyglutamine expansion downregulates specific neuronal genes before pathologic changes in SCA1. Nat. Neurosci. 3: 157-163.
37. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Günther Schütz, G., Kazuhiko Umesono, K., Bruce Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. 1995. The nuclear receptor superfamily: The second decade. Cell 83: 835-839.
38. Maniatis, T. and Reed, R. 2002. An extensive network of coupling among gene expression machines. Nature 416: 499-506.
39. Mao, Y., Senic-Matuglia, F., Di Fiore, P.P., Polo, S., Hodson, M.E., and De Camilli, P. 2005. Deubiquitinating function of ataxin-3: Insights from the solution structure of the Josephin domain. Proc. Natl. Acad. Sci. 102: 12700-12705.
40. McMahon, S.J., Pray-Grant, M.G., Schieltz, D., Yates, J.R., and Grant, P.A. 2005. Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity. Proc. Natl. Acad. Sci. 102: 8478-8482.
41. Minamiyama, M., Katsuno, M., Adachi, H., Waza, M., Sang, C., Kobayashi, Y., Tanaka, F., Doyu, M., Inukai, A., and Sobue, G. 2004. Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 13: 1183-1192.
42. Mizutani, A., Wang, L., Rajan, H., Vig, P.J.S., Alaynick, W.A., Thaler, J.P., and Tsai, C.-C. 2005. Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. EMBO J. 24: 3339-3351.
43. Muller, S., Ledl, A., and Schmidt, D. 2004. SUMO: A regulator of gene expression and genome integrity. Oncogene 23: 1998-2008.
44. Nawaz, Z. and O'Malley, B.W. 2004. Urban renewal in the nucleus: Is protein turnover by porteasomes absolutely required for nuclear receptor-regulated transcription? Mol. Endocrinol. 18: 493-499.
45. Neophytou, C., Vernallis, A.B., Smith, A., and Raff, M.C. 1997. Muller-cell-derived leukaemia inhibitory factor arrests rod photoreceptor differentiation at a postmitotic pre-rod stage of development. Development 124: 2345-2354.
46. Nicastro, G., Menon, R.P., Masino, L., Knowles, P.P., McDonald, N.Q., and Pastore, A. 2005. The solution structure of the Josephin domain of ataxin-3: Structural determinants for molecular recognition. Proc. Natl. Acad. Sci. 102: 10493-10498.
47. Nucifora Jr., F.C., Sasaki, M., Peters, M.F., Huang, H., Cooper, J.K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V.L., et al. 2001. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291: 2423-2428.
48. Nucifora Jr., F.C., Ellerby, L.M., Wellington, C.L., Wood, J.D., Herring, W.J., Sawa, A., Hayden, M.R., Dawson, V.L., Dawson, T.M., and Ross, C.A. 2003. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity. J. Biol. Chem. 278: 13047-13055.
49. Okazawa, H., Rich, T., Chang, A., Lin, X., Waragai, M., Kajikawa, M., Enokido, Y., Komuro, A., Kato, S., Shibata, M., et al. 2002. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron 34: 701-713.
50. Orr, H.T. 2001. Beyond the Qs in the polyglutamine diseases. Genes & Dev. 15: 925-932.
51. Orr, H.T., Chung, M.-Y., Banji, S., Kwiatkowski Jr., T.J., Servadio, A., Beaudet, A.L., McCall, A.E., Duvick, L.A., Ranum, L.P.W., and Zoghbi, H.Y. 1993. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 4: 221-226.
52. Palhan, V.B., Chen, S., Peng, G.H., Tjernberg, A., Gamper, A.M., Fan, Y., Chait, B.T., La Spada, A.R., and Roeder, R.G. 2005. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. Proc. Natl. Acad. Sci. 102: 8472-8477.
53. Pietrobon, D. 2002. Calcium channels and channelopathies of the central nervous system. Mol. Neurobiol. 25: 31-50.
54. Privalsky, M. 2004. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu. Rev. Physiol. 66: 315-360.
55. Reed, R. 2003. Coupling transcription, splicing and mRNA export. Curr. Opin. Cell Biol. 15: 326-331.
56. Riess, O., Schols, L., Bottger, H., Nolte, D., Vieira-Saecker, A.M., Schimming, C., Kreuz, F., Macek Jr., M., Krebsova, A., Macek, M.S., et al. 1997. SCA6 is caused by moderate CAG expansion in the α1A-voltage-dependent calcium channel gene. Hum. Mol. Genet. 6: 1289-1293.
57. Riley, B.E., Zoghbi, H.Y., and Orr, H.T. 2005. SUMOylation of the polyglutamine protein, ataxin-1 is dependent on a functional nuclear localization signal. J. Biol. Chem. 280: 21942-21948.
58. Rolfs, A., Koeppen, A., Bauer, I., Bauer, P., Buhlmann, S., Topka, H., Schols, L., and Riess, O. 2003. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann. Neurol. 54: 367-375.
59. Ross, C.A. and Poirer, M.A. 2004. Protein aggregation and neurodegenerative disease. Nat. Med. 10: S10-S17.
60. Saudou, F., Finkbeiner, S., Devys, D., and Greenberg, M.E. 1998. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55-66.
61. Scheel, H., Tomiuk, S., and Kay Hofmann, K. 2003. Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. Hum. Mol. Genet. 12: 2845-2852.
62. Schmidt, B.J., Greenberg, C.R., Allingham-Hawkins, D.J., and Sproggsm, E.L. 2002. Expression of X-linked bulbospinal muscular atrophy (Kennedy's disease) in two homozygous women. Neurology 59: 770-772.
63. Seeler, J.-S. and Dejean, A. 2003. Nuclear and unclear functions of SUMO. Nat. Rev. Cell Biol. 4: 690-699.
64. Serra, H.G., Byam, C.E., Lande, J.D., Tousey, S.K., Zoghbi, H.Y., and Orr, H.T. 2004. Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Hum. Mol. Genet. 13: 2535-2543.
65. Servadio, A., Koshy, B., Armstrong, D., Antalffy, B., Orr, H.T., and Zoghbi, H.Y. 1995. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat. Genet. 10: 94-98.
66. Skinner, P.J., Koshy, B., Klement, I.A., Helin, K., Servadio, A., Zoghbi, H.Y., and Orr, H.T. 1997. SCA1 pathogenesis involves alterations in nuclear matrix associated structures. Nature 389: 971-974.
67. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M., et al. 2001. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413: 739-743.
68. Steffan, J.S., Agrawal, N., Pallos, J., Rockabrand, E., Trotman, L.C., Slepko, N., Illes, K., Lukacsovich, T., Zhu, Y.-Z., Cattaneo, E., et al. 2004. SUMO modification of huntingtin and Huntington's disease pathology. Science 304: 100-104.
69. Sugars, K.L. and Rubinsztein, D.C. 2003. Transcriptional abnormalities in Huntington disease. Trends Genet. 19: 233-238.
70. Tait, D., Riccio, M., Sittler, A., Scherzinger, E., Santi, S., Ognibene, A., Maraldi, N.M., Lehrach, H., and Wankler, E.E. 1998. Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum. Mol. Genet. 7: 991-997.
71. Takeyama, K., Ito, S., Yamaoto, A., Tanimoto, H., Furutani, T., Kanuka, H., Miura, M., Tabata, T., and Kato, S. 2002. Androgen-dependent neurodegeneration by polyglutamineexpanded human androgen receptor in Drosophila. Neuron 35: 855-864.
72. Tanese, N. and Tjian, R. 1993. Coactivators and TAFs: A new class of eukaryotic transcription factors that connect activators to the basal machinery. Cold Spring Harb. Symp. Quant. Biol. 58: 179-185.
73. Tsai, C.C., Kao, H.Y., Mitzutani, A., Banayo, E., Rajan, H., McKeown, M., and Evans, R.M. 2004. Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc. Natl. Acad. Sci. 101: 4047-4052.
74. Tsuda, H., Jafar-Nejad, H., Patel, A.J., Sun, Y., Chen, H.-K., Rose, M.F., Venken, K.J.T., Botas, J., Orr, H.T., Hugo, J., et al. 2005. The AXH domain in mammalian/Drosophila Ataxin-1 mediates neurodegeneration in spinocerebellar ataxia 1 through its interaction with Gfi-1/Senseless proteins. Cell 122: 633-644.
75. Walker, D. and De Waard, M. 1998. Subunit interaction sites in voltage-dependent Ca2+ channels: Role in channel function. Trends Neurosci. 21: 148-154.
76. Waragai, M., Lammers, C.H., Takeuchi, S., Imafuku, I., Udagawa, Y., Kanazawa, I., Kawabata, M., Mouradian, M.M., and Okazawa, H. 1999. PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum. Mol. Genet. 8: 977-987.
77. Warrick, J.M., Morabito, L.M., Bilen, J., Gordesky-Gold, B., Faust, L.Z., Paulson, H.L., Nancy, M., and Bonini, N.M. 2005. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol. Cell 18: 37-48.
78. Yoo, S.Y., Pennesi, M.E., Weeber, E.J., Xu, B., Atkinson, R., Chen, S., Armstrong, D.L., Wu, S.M., Sweatt, J.D., and Zoghbi, H.Y. 2003. SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. Neuron 37: 383-401.
79. Yue, S., Serra, H., Zoghbi, H.Y., and Orr, H.T. 2001. The SCA1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. Hum. Mol. Genet. 10: 25-30.
80. Zhai, W., Jeong, H., Cui, L., Krainc, D., and Tjian, R. 2005. In vitro analysis of Huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell 123: 1241-1253.
81. Zhang, S., Xu, L., Lee, J., and Xu, T. 2002. Drosophila atrophin homolog functions as a transcription corepressor in multiple developmental processes. Cell 108: 45-56.
82. Zhang, J., Gray, J., Wu, L., Leone, G., Rowan, S., Cepko, C.L., Zhu, X., Craft, C.M., and Dyer, M.A. 2004. Rb regulates proliferation and rod photoreceptor development in the mouse retina. Nat. Genet. 36: 351-360.
83. Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D.W., Amos, C., Dobyns, W.B., Subramony, S.H., Zoghbi, H.Y., and Lee, C.C. 1997. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat. Genet. 15: 62-69.